Back to discover
Drug

Creatine

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as ((amino(Imino)methyl)(methyl)amino)acetic acid, (N-methylcarbamimidamido)acetic acid, (alpha-Methylguanido)acetic acid, Kreatin+7 more

((amino(Imino)methyl)(methyl)amino)acetic acid, (N-methylcarbamimidamido)acetic acid, (alpha-Methylguanido)acetic acid, Kreatin, Methylglycocyamine, N-(aminoiminomethyl)-N-methylglycine, N-amidinosarcosine, N-carbamimidoyl-N-methylglycine, N-methyl-N-guanylglycine, alpha-Methylguanidino acetic acid, Creatin.

3
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Creatine
Aliases & brands
((amino(Imino)methyl)(methyl)amino)acetic acid(N-methylcarbamimidamido)acetic acid(alpha-Methylguanido)acetic acidKreatinMethylglycocyamineN-(aminoiminomethyl)-N-methylglycineN-amidinosarcosineN-carbamimidoyl-N-methylglycineN-methyl-N-guanylglycinealpha-Methylguanidino acetic acidCreatin
RxNorm CUI
2907
ChEMBL ID
CHEMBL283800
UNII
MU72812GK0

Clinical trials

13 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
13
registered trials across all phases
LATEST COMPLETION 2017
1
Active studies
1
Recruiting
7
Late-stage (III+)
10
Completed
2
Discontinued
PHASE DISTRIBUTIONn = 13
Phase 11Phase 1 / 21Phase 24Phase 34Phase 42Phase N / A1

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19992023
Major research themes3
Adenosine Triphosphate1Creatine1Postoperative Complications1
Journals, researchers & institutions
Top journals
  • Amino acids1
  • Circulation1
  • Frontiers in immunology1
Leading researchers
  • Cook EF1
  • Donaldson MC1
  • Goldman L1
  • Ho KK1
  • Lee TH1
  • Ludwig LE1
  • Mangione CM1
  • Marcantonio ER1
Leading institutions
free-text, unnormalised
  • Biofluid Biomarker Center1
  • Brigham and Women's Hospital and Harvard Medical School1
  • Jichi Medical University1
  • School of Basic Medical Sciences1
  • Texas A&M University1

Related drugs

3 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Creatine in the shared literature.

3 shared diseases1 shared paper

Frequently co-studied with Creatine in the research literature.

1 shared paper

Frequently co-studied with Creatine in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials